Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

BACKGROUND Diabetes has been associated with an increased risk of colorectal cancer in most, but not all, studies. Findings have also been inconclusive with regard to sex and subsite in the colorectum. To resolve these inconsistencies, we conducted a meta-analysis of published data on the association between diabetes and the incidence and mortality of colorectal cancer. METHODS We identified studies by a literature search of Medline from January 1, 1966, through July 31, 2005, and by searching the reference lists of pertinent articles. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated with a random-effects model. All statistical tests were two-sided. RESULTS Analysis of 15 studies (six case-control and nine cohort studies), including 2 593 935 participants, found that diabetes was associated with an increased risk of colorectal cancer, compared with no diabetes (summary RR of colorectal cancer incidence = 1.30, 95% CI = 1.20 to 1.40), without heterogeneity between studies (P(heterogeneity) = .21). These results were consistent between case-control and cohort studies and between studies conducted in the United States and in Europe. The association between diabetes and colorectal cancer incidence did not differ statistically significantly by sex (summary RR among women = 1.33, 95% CI = 1.23 to 1.44; summary RR among men = 1.29, 95% CI = 1.15 to 1.44; P(heterogeneity) = .26) or by cancer subsite (summary RR for colon = 1.43, 95% CI = 1.28 to 1.60; summary RR for rectum = 1.33, 95% CI = 1.14 to 1.54; P(heterogeneity) = .42). Diabetes was positively associated with colorectal cancer mortality (summary RR = 1.26, 95% CI = 1.05 to 1.50), but there was evidence for heterogeneity between studies (P(heterogeneity) = .04). CONCLUSIONS Our findings strongly support a relationship between diabetes and increased risk of colon and rectal cancer in both women and men.

[1]  J. Lewis,et al.  Type 2 diabetes mellitus and the risk of colorectal cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  G A Colditz,et al.  Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. , 1999, Journal of the National Cancer Institute.

[3]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[4]  M. Thun,et al.  Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. , 2004, American journal of epidemiology.

[5]  L F Watson,et al.  Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.

[6]  H. Adami,et al.  Diabetes mellitus and risk of large bowel cancer. , 1997, Journal of the National Cancer Institute.

[7]  L. Vatten,et al.  Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.

[8]  E. Giovannucci.  Insulin and colon cancer , 1995, Cancer Causes & Control.

[9]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[10]  H. S. Himal,et al.  Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. , 1988, Cancer letters.

[11]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[12]  Walter C Willett,et al.  Dietary patterns, meat intake, and the risk of type 2 diabetes in women. , 2004, Archives of internal medicine.

[13]  E. Calle,et al.  Colorectal cancer: another complication of diabetes mellitus? , 1998, American journal of epidemiology.

[14]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[15]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[16]  N. Day,et al.  Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  Abelardo Avila-Curiel,et al.  Food, nutrition and the prevention of cancer: a global perspective , 1998 .

[18]  John C. Williams,et al.  Colon carcinoma and diabetes mellitus , 1984, Cancer.

[19]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[20]  Stampfer,et al.  Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.

[21]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[22]  M. Marmot,et al.  Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. , 1992, American journal of epidemiology.

[23]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[24]  L. Hennighausen,et al.  Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. , 2002, Cancer research.

[25]  M. Mareel,et al.  The role of bile acids in carcinogenesis. , 2001, Mutation research.

[26]  C. la Vecchia,et al.  A case-control study of diabetes mellitus and cancer risk. , 1994, British Journal of Cancer.

[27]  A. Folsom,et al.  Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  G. McKeown-Eyssen.  Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[30]  D. Silverman,et al.  Cancer risk in patients with diabetes mellitus , 1991, Cancer Causes & Control.

[31]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[32]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[33]  A. Medline,et al.  Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. , 1986, Gut.

[34]  Edward Giovannucci,et al.  Modifiable risk factors for colon cancer. , 2002, Gastroenterology clinics of North America.

[35]  C. la Vecchia,et al.  History of selected diseases and the risk of colorectal cancer. , 1991, European journal of cancer.

[36]  H. Adami,et al.  Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. , 2003, Journal of the National Cancer Institute.

[37]  M. Engelgau,et al.  The Evolving Diabetes Burden in the United States , 2004, Annals of Internal Medicine.

[38]  W. Willett,et al.  A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  L. Melton,et al.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. , 1982, Journal of chronic diseases.

[40]  M. Stampfer,et al.  A prospective study of plasma C-peptide and colorectal cancer risk in men. , 2004, Journal of the National Cancer Institute.

[41]  K. Steenland,et al.  Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  C. la Vecchia,et al.  Diabetes mellitus, family history, and colorectal cancer , 2002, Journal of epidemiology and community health.

[43]  R. Arem,et al.  Gastrointestinal tract complications of diabetes mellitus. Pathophysiology and management. , 1984, Archives of internal medicine.

[44]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[45]  S. Larsson,et al.  Diabetes and colorectal cancer incidence in the cohort of Swedish men. , 2005, Diabetes care.

[46]  M Linet,et al.  Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. , 1997, Journal of the National Cancer Institute.

[47]  B. A. O'Mara,et al.  Diabetes mellitus and cancer risk: a multisite case-control study. , 1985, Journal of chronic diseases.

[48]  F. Hu,et al.  Primary prevention of diabetes: what can be done and how much can be prevented? , 2005, Annual review of public health.

[49]  L. Kolonel,et al.  Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. , 1997, Cancer research.

[50]  L S Geiss,et al.  Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.

[51]  John D. Potter,et al.  Food, nutrition and the prevention of cancer : a global perspective , 2001 .

[52]  J. Lewis,et al.  Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. , 2004, Gastroenterology.

[53]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[54]  D. Dunger,et al.  Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. , 2002, Journal of the National Cancer Institute.

[55]  I. I. Kessler.  Cancer mortality among diabetics. , 1970, Journal of the National Cancer Institute.

[56]  E. Giovannucci.  Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.

[57]  L H Kuller,et al.  Increased blood glucose and insulin, body size, and incident colorectal cancer. , 1999, Journal of the National Cancer Institute.

[58]  C. la Vecchia,et al.  Diabetes mellitus and colorectal cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.